Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

1.

An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies.

Padron E, Garcia-Manero G, Patnaik MM, Itzykson R, Lasho T, Nazha A, Rampal RK, Sanchez ME, Jabbour E, Al Ali NH, Thompson Z, Colla S, Fenaux P, Kantarjian HM, Killick S, Sekeres MA, List AF, Onida F, Komrokji RS, Tefferi A, Solary E.

Blood Cancer J. 2015 Jul 31;5:e333. doi: 10.1038/bcj.2015.53.

PMID:
26230957
2.

Chronic Myelomonocytic Leukemia: a Genetic and Clinical Update.

McCullough KB, Patnaik MM.

Curr Hematol Malig Rep. 2015 Jun 28. [Epub ahead of print]

PMID:
26122388
3.

Temozolomide induced bone marrow Suppression-A single institution outcome analysis and review of the literature.

Kourelis TV, Buckner JC, Gangat N, Patnaik MM.

Am J Hematol. 2015 May 25. doi: 10.1002/ajh.24066. [Epub ahead of print] No abstract available.

PMID:
26010271
4.

ASXL1 mutated chronic myelomonocytic leukemia in a patient with familial thrombocytopenia secondary to germline mutation in ANKRD26.

Perez Botero J, Oliveira JL, Chen D, Reichard KK, Viswanatha DS, Nguyen PL, Pruthi RK, Majerus J, Gada P, Gangat N, Tefferi A, Patnaik MM.

Blood Cancer J. 2015 May 22;5:e315. doi: 10.1038/bcj.2015.41. No abstract available.

5.

Refractory anemia with ring sideroblasts and RARS with thrombocytosis.

Patnaik MM, Tefferi A.

Am J Hematol. 2015 Jun;90(6):549-59. doi: 10.1002/ajh.24038. Review.

PMID:
25899435
6.

Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome.

Patnaik MM, Wassie EA, Padron E, Onida F, Itzykson R, Lasho TL, Kosmider O, Finke CM, Hanson CA, Ketterling RP, Komrokji R, Tefferi A, Solary E.

Blood Cancer J. 2015 Feb 13;5:e280. doi: 10.1038/bcj.2015.9. No abstract available.

7.

Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients.

Wojenski DJ, Bartoo GT, Merten JA, Dierkhising RA, Barajas MR, El-Azhary RA, Wilson JW, Plevak MF, Hogan WJ, Litzow MR, Patnaik MM, Wolf RC, Hashmi SK.

Transpl Infect Dis. 2015 Apr;17(2):250-8. doi: 10.1111/tid.12367.

PMID:
25661996
8.

Blast transformation in chronic myelomonocytic leukemia: Risk factors, genetic features, survival, and treatment outcome.

Patnaik MM, Wassie EA, Lasho TL, Hanson CA, Ketterling R, Tefferi A.

Am J Hematol. 2015 May;90(5):411-6. doi: 10.1002/ajh.23962. Epub 2015 Apr 1.

PMID:
25645147
9.

Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast cells.

Pardanani A, Lasho T, Chen D, Kimlinger TK, Finke C, Zblewski D, Patnaik MM, Reichard KK, Rowinsky E, Hanson CA, Brooks C, Tefferi A.

Leukemia. 2015 Jul;29(7):1605-8. doi: 10.1038/leu.2015.16. Epub 2015 Feb 2. No abstract available.

PMID:
25640886
10.

Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations.

Mir MA, Kochuparambil ST, Abraham RS, Rodriguez V, Howard M, Hsu AP, Jackson AE, Holland SM, Patnaik MM.

Cancer Med. 2015 Apr;4(4):490-9. doi: 10.1002/cam4.384. Epub 2015 Jan 26.

11.

Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome.

Patnaik MM, Wassie EA, Padron E, Onida F, Itzykson R, Lasho TL, Kosmider O, Finke CM, Hanson CA, Ketterling RP, Komrokji R, Tefferi A, Solary E.

Blood Cancer J. 2015 Jan 2;5:e270. doi: 10.1038/bcj.2014.90. Erratum in: Blood Cancer J. 2015;5:e280. Blood Cancer J. 2015;5:e280.

PMID:
25555161
12.

MYST3/CREBBP Rearranged Acute Myeloid Leukemia after Adjuvant Chemotherapy for Breast Cancer.

Gupta A, Patnaik MM, Naina HV.

Case Rep Oncol Med. 2014;2014:361748. doi: 10.1155/2014/361748. Epub 2014 Dec 8.

13.

Impact of clinical factors and allograft leukocyte content on post-transplant lymphopenia, monocytopenia, and survival in patients undergoing allogeneic peripheral blood haematopoietic cell transplant.

Thoma MD, Glejf J, Jacob E, Huneke TJ, DeCook LJ, Johnson ND, Patnaik MM, Litzow MR, Hogan WJ, Newell LF, Chandran R, Porrata LF, Holtan SG.

BMC Hematol. 2014 Sep 1;14(1):14. doi: 10.1186/2052-1839-14-14. eCollection 2014.

14.

Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic-French Consortium Study.

Wassie EA, Itzykson R, Lasho TL, Kosmider O, Finke CM, Hanson CA, Ketterling RP, Solary E, Tefferi A, Patnaik MM.

Am J Hematol. 2014 Dec;89(12):1111-5. doi: 10.1002/ajh.23846. Epub 2014 Sep 26.

PMID:
25195656
15.

ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients.

Patnaik MM, Itzykson R, Lasho TL, Kosmider O, Finke CM, Hanson CA, Knudson RA, Ketterling RP, Tefferi A, Solary E.

Leukemia. 2014 Nov;28(11):2206-12. doi: 10.1038/leu.2014.125. Epub 2014 Apr 3.

PMID:
24695057
16.

CALR mutations are infrequent in WHO-defined refractory anemia with ring sideroblasts.

Patnaik MM, Belachew A, Finke C, Lasho TL, Hanson CA, Tefferi A.

Leukemia. 2014 Jun;28(6):1370-1. doi: 10.1038/leu.2014.47. Epub 2014 Jan 30. No abstract available.

PMID:
24476767
17.

Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological review.

Patnaik MM, Parikh SA, Hanson CA, Tefferi A.

Br J Haematol. 2014 May;165(3):273-86. doi: 10.1111/bjh.12756. Epub 2014 Jan 28. Review.

PMID:
24467717
18.

Safety of pegfilgrastim (neulasta) in patients with sickle cell trait/anemia.

Kasi PM, Patnaik MM, Peethambaram PP.

Case Rep Hematol. 2013;2013:146938. doi: 10.1155/2013/146938. Epub 2013 Dec 11.

19.

Spontaneous coronary artery dissection during hematopoietic stem cell infusion.

Mir MA, Patnaik MM, Herrmann J.

Blood. 2013 Nov 7;122(19):3388-9. doi: 10.1182/blood-2013-09-528760. No abstract available.

20.

In reply-dabigatran for heparin-induced thrombocytopenia.

Gonsalves WI, Pruthi RK, Patnaik MM.

Mayo Clin Proc. 2013 Sep;88(9):1036-7. doi: 10.1016/j.mayocp.2013.06.014. No abstract available.

PMID:
24001500
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk